Asporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer

Por Maris, Pamela, Blomme, Arnaud, Palacios, Ana Perez, Costanza, Brunella, Bellahcène, Akeila, Bianchi, Elettra, Gofflot, Stephanie, Drion, Pierre, Trombino, Giovanna Elvi, Di Valentin, Emmanuel, Cusumano, Pino G., Maweja, Sylvie, Jerusalem, Guy, Delvenne, Philippe, Lifrange, Eric, Castronovo, Vincent, Turtoi, Andrei
Publicado no PLoS Med (2015)

Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast Cancer

Por Metzger-Filho, Otto, Catteau, Aurélie, Michiels, Stefan, Buyse, Marc, Ignatiadis, Michail, Saini, Kamal S., de Azambuja, Evandro, Fasolo, Virginie, Naji, Sihem, Canon, Jean Luc, Delrée, Paul, Coibion, Michel, Cusumano, Pino, Jossa, Veronique, Kains, Jean Pierre, Larsimont, Denis, Richard, Vincent, Faverly, Daniel, Cornez, Nathalie, Vuylsteke, Peter, Vanderschueren, Brigitte, Peyro-Saint-Paul, Hélène, Piccart, Martine, Sotiriou, Christos
Publicado em 2013